Back to Search Start Over

Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1

Authors :
Peiwei Chai
Yingxiu Luo
Chuandi Zhou
Yefei Wang
Xianqun Fan
Renbing Jia
Source :
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-9 (2019)
Publication Year :
2019
Publisher :
BMC, 2019.

Abstract

Abstract Background Orbital/periorbital plexiform neurofibroma (OPPN) can compromise physical appearance and visual function. However, the clinical characteristics and NF1 mutation landscape in patients with heritable OPPN have not been reported. Methods The medical charts of 26 Chinese patients with OPPN from 12 families were reviewed. Mutation analysis of the entire coding region and flanking splice sites of the NF1 gene was performed using next-generation sequencing (NGS). Novel NF1 mutations were confirmed by Sanger sequencing. Results Compared to the parental generation, a significantly larger proportion of OPPN patients in the successive generation presented with earlier onset (p = 0.001), amblyopia (p = 0.034), motility disorders (p = 0.009) and bony orbital expansion (p = 0.019). Six novel NF1 mutations were identified in 11 (91.67%) families, including 6 (42.9%) single-base substitutions, 4 (28.5%) splicing mutations, 3 (21.4%) frameshift deletions, and 1 (7.14%) intron mutation. Conclusions The successive generation of OPPN patients presented with earlier onset and exhibited more severe ocular signs than did their parents or grandparents. Special attention should be paid to successive generations of OPPN patients. Considering that 6 mutations were novel, comprehensive NF1 mutation analysis is required or necessary or proposed for genetic counselling.

Details

Language :
English
ISSN :
14712350
Volume :
20
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Medical Genetics
Publication Type :
Academic Journal
Accession number :
edsdoj.05be0d220f384509a4bae4981823ca65
Document Type :
article
Full Text :
https://doi.org/10.1186/s12881-019-0877-9